| scholarly article | Q13442814 |
| P50 | author | Florian Gembardt | Q57010412 |
| P2093 | author name string | Thomas Walther | |
| Heinz-Peter Schultheiss | |||
| Anja Sterner-Kock | |||
| Matthias Spalteholz | |||
| Hans Imboden | |||
| Wolf-Eberhard Siems | |||
| Franziska Reibitz | |||
| P2860 | cites work | Imprinting of the Murine Mas Protooncogene Is Restricted to Its Antisense RNA | Q56963615 |
| Enhanced Renal Immunocytochemical Expression of ANG-(1-7) and ACE2 During Pregnancy | Q57185045 | ||
| Immunocytochemical localization of angiotensin-(1-7) in the rat forebrain | Q68070073 | ||
| Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria | Q72196103 | ||
| Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators | Q72232746 | ||
| Remodeling of myocardium and arteries by chronic angiotensin converting enzyme inhibition in hypertensive patients | Q72817086 | ||
| Vascular gp91(phox): beyond the endothelium | Q73964025 | ||
| Distribution of neutral endopeptidase activity along the rat and rabbit nephron | Q77824037 | ||
| Cardiac Angiotensin-(1-7) in Ischemic Cardiomyopathy | Q79096678 | ||
| A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase | Q22254730 | ||
| A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 | Q24290169 | ||
| Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins | Q24321922 | ||
| Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas | Q24680069 | ||
| ACE2 gene expression is up-regulated in the human failing heart | Q24794580 | ||
| Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase | Q28115041 | ||
| Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus | Q28188496 | ||
| Angiotensin-converting enzyme 2 is an essential regulator of heart function | Q28205840 | ||
| Cell type-specific expression of the Mas proto-oncogene in testis | Q28215442 | ||
| Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme | Q28216431 | ||
| Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues | Q28583988 | ||
| Novel peptide inhibitors of angiotensin-converting enzyme 2. | Q31133376 | ||
| Angiotensin-(1-7): an update. | Q34019825 | ||
| Vasopeptidase inhibitors: an emerging class of cardiovascular drugs | Q34175462 | ||
| Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension | Q34337780 | ||
| Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? | Q34395664 | ||
| The angiotensin-converting enzyme gene family: genomics and pharmacology | Q34586915 | ||
| The role of ACE2 in cardiovascular physiology | Q35105871 | ||
| Vasopeptidase inhibitors: will they have a role in clinical practice? | Q35608907 | ||
| Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation. | Q35833603 | ||
| Insights into angiotensin II receptor function through AT2 receptor knockout mice | Q35850538 | ||
| Novel angiotensin peptides | Q35953173 | ||
| Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. | Q40510688 | ||
| Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor | Q40546105 | ||
| A point mutation in the juxtamembrane stalk of human angiotensin I-converting enzyme invokes the action of a distinct secretase | Q40818059 | ||
| Counterregulatory actions of angiotensin-(1-7). | Q41607078 | ||
| Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion | Q43744776 | ||
| Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles | Q43920054 | ||
| AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats. | Q44086912 | ||
| Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. | Q44592757 | ||
| Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors | Q44790566 | ||
| Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). | Q47278854 | ||
| Angiotensin-(1-7) immunoreactivity in the hypothalamus of the (mRen-2d)27 transgenic rat. | Q47836966 | ||
| Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the rat. | Q48313520 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 1270-1277 | |
| P577 | publication date | 2005-02-16 | |
| P1433 | published in | Peptides | Q7166533 |
| P1476 | title | Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents | |
| P478 | volume | 26 |
| Q37738188 | A Fluorometric Method of Measuring Carboxypeptidase Activities for Angiotensin II and Apelin-13 |
| Q45287587 | ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats |
| Q36877738 | ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. |
| Q37826865 | ACE2, a promising therapeutic target for pulmonary hypertension |
| Q56774944 | ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats |
| Q55465043 | Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7). |
| Q39035728 | Alternative renin-angiotensin system pathways in adipose tissue and their role in the pathogenesis of obesity |
| Q91703665 | Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System |
| Q35968824 | Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice |
| Q40162845 | Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung |
| Q36020040 | Angiotensin converting enzyme 2: a new important player in the regulation of glycemia |
| Q36416940 | Angiotensin peptides and their pleiotropic actions |
| Q40373012 | Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells |
| Q38207841 | Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets |
| Q37068454 | Angiotensin-converting enzyme 2 and the kidney |
| Q37155907 | Angiotensin-converting enzyme 2 in the brain: properties and future directions |
| Q35952628 | Anti-Inflammatory Action of Angiotensin 1-7 in Experimental Colitis |
| Q33319072 | Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice |
| Q91717735 | COVID-19: Risk Groups, Mechanistic Insights, and Challenges |
| Q33844005 | Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts |
| Q37608588 | Cardiovascular protection by angiotensin-converting enzyme 2: a new paradigm |
| Q37729150 | Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse |
| Q98178294 | Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2 |
| Q40128591 | Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted |
| Q43238313 | Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension |
| Q44985835 | Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas. |
| Q39420474 | Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation |
| Q40134736 | Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats |
| Q46715078 | Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes |
| Q45973849 | Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice. |
| Q52604902 | Inflammation Alters Angiotensin Converting Enzymes (ACE and ACE-2) Balance in Rat Heart |
| Q42020947 | Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. |
| Q37595616 | Losartan chemistry and its effects via AT1 mechanisms in the kidney |
| Q42196827 | Mesenchymal stem cell-based angiotensin-converting enzyme 2 in treatment of acute lung injury rat induced by bleomycin |
| Q28086792 | Multifaceted interplay among mediators and regulators of intestinal glucose absorption: potential impacts on diabetes research and treatment |
| Q37599394 | Not just angiotensinases: new roles for the angiotensin-converting enzymes |
| Q96690341 | Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (COVID-19) |
| Q48684263 | Ontogeny of angiotensin-converting enzyme 2. |
| Q98153547 | Organ-specific manifestations of COVID-19 infection |
| Q28279771 | Physiology of kidney renin |
| Q55641730 | Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis. |
| Q35726197 | Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling |
| Q46483030 | Renal ACE2 expression and activity is unaltered during established hypertension in adult SHRSP and TGR(mREN2)27. |
| Q58919241 | Renin Angiotensin System in Cognitive Function and Dementia |
| Q26821967 | Review article: pancreatic renin-angiotensin systems in health and disease |
| Q37081415 | Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure |
| Q34892110 | Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure |
| Q37357429 | The adipose renin-angiotensin system: role in cardiovascular disease. |
| Q38979226 | The adipose tissue and the involvement of the renin-angiotensin-aldosterone system in cardiometabolic syndrome |
| Q36804138 | The emerging role of ACE2 in physiology and disease |
| Q93237239 | The pivotal link between ACE2 deficiency and SARS-CoV-2 infection |
| Q36550987 | The renin angiotensin aldosterone system and insulin resistance in humans |
| Q33915412 | The renin angiotensin system and the metabolic syndrome |
| Q37178255 | The sweeter side of ACE2: physiological evidence for a role in diabetes |
| Q36830120 | Therapeutic time window for angiotensin-(1-7) in acute lung injury |
| Q36742531 | Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-alpha knock-out mice |
| Q38006726 | Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options. |
| Q54496318 | Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport. |
Search more.